1 / 29

Aortic Stenosis & Non-Cardiac Surgery

Aortic Stenosis & Non-Cardiac Surgery Stephen R. Ellis, MD David Warters, MD ABG: 7.58/32/472/30/8.2 Na/K 139/3.8 HCT 44 Introduction

Ava
Download Presentation

Aortic Stenosis & Non-Cardiac Surgery

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Aortic Stenosis & Non-Cardiac Surgery Stephen R. Ellis, MD David Warters, MD

  2. ABG: 7.58/32/472/30/8.2 Na/K 139/3.8 HCT 44

  3. Introduction • Aortic stenosis derives its position as the most important valvular lesion because of its potential for sudden death (15–20%), and because of the inability to obtain adequate systemic perfusion by external cardiac massage during a cardiac arrest.

  4. Introduction • Aorticstenosiswithout accompanying mitral valve disease is more common in men than in women and very rarely occurs on a rheumatic basis. Instead, isolated AS is usually either congenital or degenerative in origin. • The natural history of the disease is of a long asymptomatic latent period followed by the onset of characteristic symptoms (angina, syncope, dyspnea).

  5. Etiology • Degenerative calcific aortic stenosis • Mechanical stress over time leads to progressive fibrosis and calcification of a previously normal tri-leaflet valve. • Initially, this process is seen as sclerosis. • It is an early form of the disease that can progress to stenosis. • associated with many of the risk factors for coronary artery disease - diabetes, hypercholesterolaemia, smoking and hypertension.

  6. Etiology • Congenital bicuspid aortic valve • Bicuspid aortic valve is the most common congenital cardiac malformation ( 2% of general population). • abnormal valve structure - two rather than three leaflets - leads to turbulent flow, which, in turn, can produce fibrosis, calcification and orifice narrowing secondary to trauma. • commonly produces symptoms in the fourth to sixth decades of life. • accounts for 50% of patients <70 yr requiring aortic valve surgery for stenosis but only 25% of those >70 yr.

  7. Etiology • Rheumatic AS • results from adhesions and fusions of the commissures and cusps • There is vascularization of the leaflets of the valve ring • This leads to retraction and stiffening of the free borders of the cusps. • Calcific nodules develop on both surfaces, and the orifice is reduced to a small round or triangular opening. • As a consequence, the rheumatic valve is often regurgitant and stenotic

  8. Normal aortic valve. Congenital aortic stenosis. Rheumatic aortic stenosis. Calcific aortic stenosis. Calcific senile aortic stenosis. Etiology

  9. Classification • Mild AS – AVA 1.2-1.8cm2, mean gradient 12-25 mmHg • Moderate AS – AVA 0.8-1.2cm2, mean gradient 40-50 mmHg • Severe AS – AVA <0.8cm2, mean gradient > 50 mmHg

  10. Pathophysiology • The normal aortic valve area (AVA) is 2.6–3.5 cm2 in adults. • Hemodynamically significant obstruction occurs as the AVA approaches 1.0 cm2. • Increasing obstruction hypertrophy, which allows the LV to maintain a pressure gradient across the valve without dilating or reducing the cardiac output.

  11. Pathophysiology • However, over time the hypertrophied ventricle becomes increasingly stiff, diastolic dysfunction with a reduced compliance. • This is transmitted to the pulmonary circulation pulmonary edema

  12. Pathophysiology • A normal sinus rhythm is beneficial as the left atrial kick accounts for 40% of LV filling. • LA hypertrophies secondary to this increased demand on it increased chance of atrial fibrillation. • Major alterations of myocardial oxygen supply and demand occur. • The ventricle becomes • very sensitive to changes in preload • dependent on the maintenance of sinus rhythm • susceptible to ischemia, especially when arterial pressure is reduced.

  13. Pathophysiology • Eventually, cardiac output, stroke volume and therefore pressure gradient across the valve fall. • Left ventricular dilatation occurs late in the disease process

  14. There is a direct relationship b/w the aortic valve area and the flow across the valve. Blood flow is not significantly impeded until the aortic valve area is < 0.5-0.7 cm2 Pathophysiology

  15. Pathophysiology

  16. Assessment - Symptoms • As stated the three cardinal signs of AS are – angina, syncope, and dyspnea. • Angina • occurs as oxygen demand from the hypertrophied LV outstrips the supply • Initial symptom in 50-70% of pts • Syncope • etiology unclear • Initial symptom in 15-30% of pts

  17. Assessment - Symptoms • Dyspnea – pulmonary congestion, CHF • Symptoms that develop late in AS, and reflect inc pulmonary HTN – exertional dyspnea, orthopnea, PND, pulmonary edema

  18. Assessment - Exam • Arterial pulse is slow rising, and of low volume • Carotid thrill • Precordial thrill with leaning forward during expiration • Late systolic murmur (2nd intercostal space at base of heart)

  19. Assessment - Exam • EKG: • LVH – present in ~ 85% of pts • T-wave inversion & ST depression as hypertrophy becomes worse • AV and intraventricular blocks can be seen

  20. Assessment - Exam • ECHO: • Used to assess the anatomy of the aortic valve, grade the stenosis, and assess LV function.

  21. Assessment - Exam • ECHO:

  22. Anesthetic Management for Non-Cardiac Surgery • Careful hemodynamic monitoring is essential: • Arterial line • Aorticstenosis produces a fixed obstruction to left ventricular ejection that results in reduced stroke volume and an arterial pressure waveform that rises slowly (pulsus tardus) and peaks late in systole • Pulsus parvus (narrow pulse pressure) • CVC, or large bore PIVs • Swan-Ganz? Absolutely not, as the potential for it to precipitate arrhythmias is too high. • TEE is appropriate if available

  23. Anesthetic Management for AS & Non-Cardiac Surgery • Avoid systemic hypotension • leads to myocardial ischemia, and then decreased contractility and a vicious cycle ensues. • vasoconstrictors must be at hand – consider an infusion from the beginning • treat hypotension aggressively • Maintain sinus rhythm • sinus tachy decreases diastolic time for myocardial perfusion • sinus brady limits CO in pts with fixed stroke volume

  24. Anesthetic Management for AS & Non-Cardiac Surgery • Treat arrhythmias promptly • Contractility • Stroke volume is maintained with a heightened contractile state • Maintain adequate intravascular volume to ensure ventricular filling • b/c of dec LV compliance and inc LVEDP & LVEDV, preload augmentation is needed for a normal stroke volume

  25. Anesthetic Management for AS & Non-Cardiac Surgery • GA vs Regional: • successful use of spinal and epidural have been reported. • Can use combined lumbar plexus and sciatic PNB for hips • GA is safe, as long as care is taken to maintain blood pressure and sinus rhythm • Narcotic-based technique is often used

  26. Postoperative Management • Monitored bed with invasive monitoring, and adequate pain control. • Maintain appropriate intravascular filling, blood pressure and sinus rhythm.

  27. References • Brown , J et al. Aortic Stenosis and Non-Cardiac Surgery. Continuing Education in Anaesthesia, Critical Care & Pain 2005 5(1):1-4 • Hensley F, Martin DE, Gravlee GP. A Practical Approach to Cardiac Anesthesia, 3rd ed. Philadelphia: LWW, 2003:303-309 • Miller, RD. Anesthesia, 5th ed. Philadelphia: Churchill Livingstone, 2000: 1770-1771 • Miller, RD. Anesthesia, 6th ed. Philadelphia: Churchill Livingstone, 2000: 1954-1957 • Braunwald. Heart Disease: A Textbook of Cardiovascular Medicine, 6th ed. Philadelphia: WB Saunders, 2001:1671-1680

More Related